JPMorgan Chase & Co’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Hold
0
-$21K 5908
2021
Q4
Hold
0
5315